Neurotoxic properties of the Zika virus envelope protein.


Journal

Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712

Informations de publication

Date de publication:
09 2023
Historique:
received: 28 02 2023
revised: 31 05 2023
accepted: 11 06 2023
pmc-release: 01 09 2024
medline: 24 7 2023
pubmed: 17 6 2023
entrez: 16 6 2023
Statut: ppublish

Résumé

Prenatal Zika virus (ZIKV) infection is a serious global concern as it can lead to brain injury and many serious birth defects, collectively known as congenital Zika syndrome. Brain injury likely results from viral mediated toxicity in neural progenitor cells. Additionally, postnatal ZIKV infections have been linked to neurological complications, yet the mechanisms driving these manifestations are not well understood. Existing data suggest that the ZIKV envelope protein can persist in the central nervous system for extended periods of time, but it is unknown if this protein can independently contribute to neuronal toxicity. Here we find that the ZIKV envelope protein is neurotoxic, leading to overexpression of poly adenosine diphosphate -ribose polymerase 1, which can induce parthanatos. Together, these data suggest that neuronal toxicity resulting from the envelope protein may contribute to the pathogenesis of post-natal ZIKV-related neurologic complications.

Identifiants

pubmed: 37327963
pii: S0014-4886(23)00154-1
doi: 10.1016/j.expneurol.2023.114469
pmc: PMC10527427
mid: NIHMS1911681
pii:
doi:

Substances chimiques

Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

114469

Subventions

Organisme : Intramural NIH HHS
ID : ZIA NS003130
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing financial interests or other competing interests.

Références

Cell Stem Cell. 2017 Aug 3;21(2):274-283.e5
pubmed: 28736217
Brain Inj. 2021 Jun 7;35(7):831-841
pubmed: 33818227
Viruses. 2018 Nov 17;10(11):
pubmed: 30453621
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31365-31375
pubmed: 33229545
Nat Rev Cancer. 2010 Apr;10(4):293-301
pubmed: 20200537
Ann Neurol. 2000 Feb;47(2):186-94
pubmed: 10665489
Sci Transl Med. 2018 Apr 4;10(435):
pubmed: 29618564
Front Biosci (Landmark Ed). 2009 Jan 01;14(3):1116-28
pubmed: 19273119
Brain Res. 1995 Apr 24;678(1-2):200-6
pubmed: 7620888
Science. 2016 May 13;352(6287):816-8
pubmed: 27064148
Clin Infect Dis. 2017 Mar 1;64(5):675-677
pubmed: 27927858
Sci Transl Med. 2015 Sep 30;7(307):307ra153
pubmed: 26424568
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Lancet. 2016 Apr 2;387(10026):1481
pubmed: 26946926
J Proteome Res. 2020 Jun 5;19(6):2391-2403
pubmed: 32357013
Neuron. 2023 Apr 5;111(7):1086-1093.e2
pubmed: 36669485
J Neuroimmune Pharmacol. 2017 Jun;12(2):314-326
pubmed: 28005232
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9685-90
pubmed: 16769901
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18308-13
pubmed: 17116882
Ann Neurol. 2022 Oct;92(4):545-561
pubmed: 35801347
Anal Chem. 2022 Jan 18;94(2):1365-1372
pubmed: 34928595
J Neurosci. 2007 Oct 10;27(41):11047-55
pubmed: 17928446
PLoS Pathog. 2020 Dec 10;16(12):e1008689
pubmed: 33301527
Curr Opin Neurol. 2023 Jun 1;36(3):198-206
pubmed: 37078647
Ann Neurol. 2019 Nov;86(5):695-703
pubmed: 31461177
Int J Mol Sci. 2021 Nov 05;22(21):
pubmed: 34769416
Pediatr Neurol. 2018 Aug;85:16-20
pubmed: 30343688
Brain Behav Immun Health. 2020 Jul 18;7:100105
pubmed: 34589866
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):193-198
pubmed: 29346650
Emerg Infect Dis. 2017 Jun;23(6):1047-1048
pubmed: 28518023
Emerg Infect Dis. 2014 Jun;20(6):1085-6
pubmed: 24856001
Viruses. 2021 Nov 20;13(11):
pubmed: 34835123
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):59-62
pubmed: 26820244
Neurotherapeutics. 2022 Jul;19(4):1313-1328
pubmed: 35831747
IUBMB Life. 2022 Aug;74(8):812-825
pubmed: 35102668
Neurotherapeutics. 2015 Jan;12(1):200-16
pubmed: 25404050
BMC Infect Dis. 2018 Aug 10;18(1):388
pubmed: 30097025
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):223-9
pubmed: 9402067
N Engl J Med. 2018 Mar 15;378(11):985-994
pubmed: 29539287
Cell Rep. 2017 Oct 31;21(5):1180-1190
pubmed: 29091758
PLoS Pathog. 2020 May 1;16(5):e1008204
pubmed: 32357162
mBio. 2017 Apr 25;8(2):
pubmed: 28442607
Euro Surveill. 2016 Apr 21;21(16):
pubmed: 27123558
J Neurovirol. 2013 Oct;19(5):418-31
pubmed: 23982957
J Biomol Screen. 2014 Jan;19(1):32-43
pubmed: 24019252
Paediatr Perinat Epidemiol. 2017 Nov;31(6):537-545
pubmed: 28806479
Sci Signal. 2020 Dec 22;13(663):
pubmed: 33443209
Biomedicines. 2019 Nov 06;7(4):
pubmed: 31698798
J Biol Chem. 2001 Nov 2;276(44):40910-6
pubmed: 11533051
Cell Stem Cell. 2016 May 5;18(5):587-90
pubmed: 26952870
Ann N Y Acad Sci. 2020 Jul;1471(1):18-56
pubmed: 30875083
Transl Stroke Res. 2023 Jan 12;:
pubmed: 36633794
JAMA Neurol. 2017 Oct 1;74(10):1190-1198
pubmed: 28806453
Mayo Clin Proc. 2016 Apr;91(4):514-21
pubmed: 27046524
Trop Med Infect Dis. 2021 Jun 01;6(2):
pubmed: 34205913
Cell. 2017 May 4;169(4):610-620.e14
pubmed: 28457610
J Clin Neurosci. 2021 Apr;86:50-57
pubmed: 33775346
Virology. 2019 Nov;537:254-262
pubmed: 31539774
Front Immunol. 2017 Aug 23;8:1016
pubmed: 28878777
Sci Rep. 2022 Jul 30;12(1):13125
pubmed: 35908049
Neurotoxicology. 2014 Dec;45:192-200
pubmed: 25454721
Neurotherapeutics. 2017 Oct;14(4):1027-1048
pubmed: 28952036
Nat Med. 2016 Oct;22(10):1101-1107
pubmed: 27571349
Nature. 2016 May 11;534(7606):267-71
pubmed: 27279226
Cell Stem Cell. 2016 Jul 7;19(1):120-6
pubmed: 27179424
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):73-79
pubmed: 35051132
PLoS Negl Trop Dis. 2022 Jul 29;16(7):e0010656
pubmed: 35905074
J Neuroinflammation. 2022 Feb 7;19(1):40
pubmed: 35130924
Neuroscience. 1999;91(4):1369-78
pubmed: 10391443
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Cell Stem Cell. 2019 Jun 6;24(6):1006
pubmed: 31173705
Adv Neuroimmunol. 1994;4(3):167-73
pubmed: 7533039
J Neurovirol. 2012 Dec;18(6):445-55
pubmed: 22886603
J Virol. 2019 May 29;93(12):
pubmed: 30944176
Nat Neurosci. 2019 Aug;22(8):1276-1288
pubmed: 31235930
Lancet. 2016 Jan 16;387(10015):227-8
pubmed: 26775124
Acta Neuropathol. 2017 Jun;133(6):983-999
pubmed: 28332092
PLoS One. 2010 May 14;5(5):e10649
pubmed: 20498839
Nat Commun. 2021 Sep 6;12(1):5305
pubmed: 34489447

Auteurs

Joseph P Steiner (JP)

Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Muznabanu Bachani (M)

Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Nasir Malik (N)

Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Wenxue Li (W)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Richa Tyagi (R)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Kevon Sampson (K)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Rachel P M Abrams (RPM)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Youssef Kousa (Y)

Division of Neurology, Children's National Hospital, Washington, DC 20010, USA; Department of Genomics and Precision Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC 20052, USA.

Jamie Solis (J)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Tory P Johnson (TP)

Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.

Avindra Nath (A)

Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: natha@ninds.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH